Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nektar Therapeutics
(NQ:
NKTR
)
1.330
+0.080 (+6.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Nektar Therapeutics
< Previous
1
2
3
4
5
Next >
Tesla To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Monday
March 06, 2023
Citigroup raised the price target for The Manitowoc Company, Inc. (NYSE: MTW) from $11 to $21. Citigroup analyst Timothy Thein maintained a Neutral rating. Manitowoc shares fell 2.4% to $19.09 in...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
During Tuesday, 79 stocks hit new 52-week lows.
Via
Benzinga
Expert Ratings for Nektar Therapeutics
May 31, 2022
Within the last quarter, Nektar Therapeutics (NASDAQ:NKTR) has observed the following analyst ratings:
Via
Benzinga
Dow Dips 350 Points; S&P 500 Down Over 1%
February 24, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Friday. The Dow traded down 1.07% to 32,798.91 while the NASDAQ fell 1.90% to 11,370.53. The S&P 500...
Via
Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 24, 2023
Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 24, 2023
Via
Benzinga
Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher
February 24, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Friday. The Dow traded down 1.39% to 32,692.94 while the NASDAQ fell 2.14% to 11,342.36. The S&P 500 also...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
Via
Benzinga
US Stocks Open Lower; Dow Drops 1%
February 24, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Friday. Following the market opening Friday, the Dow traded down 1.05% to 32,807.33 while the NASDAQ fell 1.52% to...
Via
Benzinga
PIXY Stock Alert: What to Know as ShiftPixy Utilizes ChatGPT for Recruiting
February 24, 2023
ShiftPixy (PIXY) stock is on the move Friday after the company announced plans to use ChatGPT for recruiting and hiring.
Via
InvestorPlace
BA Stock Alert: Boeing Halts Deliveries of 787 Dreamliners
February 24, 2023
Boeing (BA) stock is a hot topic among traders on Friday after the aerospace company halted deliveries of its 787 Dreamliner.
Via
InvestorPlace
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
February 24, 2023
Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data.
Via
InvestorPlace
Why Nektar Therapeutics Stock Is Plunging Today
February 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 24, 2023
Via
Benzinga
Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
February 24, 2023
Gainers Cingulate Inc (NASDAQ: CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 24, 2023
It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!
Via
InvestorPlace
US Stocks Stare At More Losses In a Lackluster Week: Can Inflation Data Salvage Year's Rally?
February 24, 2023
See-sawing sentiment continues to persist on Wall Street, as index futures signal weakness on Friday after Thursday's positive close. A key inflation reading due ahead of the market opening may largely...
Via
Benzinga
BigCommerce, ContextLogic And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 24, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
During Wednesday's session, 107 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 29, 2022
Via
Benzinga
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
Via
Benzinga
Nasdaq, S&P 500 Futures Pullback At Start Of New Trading Week As Rate Fears Return To Haunt; AMD, Tesla, Biogen, Eli Lilly, JD In Focus
November 14, 2022
The major U.S. index futures are pointing to a moderately lower opening on Wall Street on Monday, as optimism following a tamer inflation data gives way to apprehension. The yield on the benchmark...
Via
Benzinga
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
October 07, 2022
Via
Benzinga
Nektar Therapeutics's Return On Capital Employed Insights
August 23, 2022
Nektar Therapeutics (NASDAQ:NKTR) brought in sales totaling $21.59 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 75.97%, resulting in a loss of $159.07...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 05, 2022
Via
Benzinga
Recap: Nektar Therapeutics Q2 Earnings
August 04, 2022
Nektar Therapeutics (NASDAQ:NKTR) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
July 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Nektar Therapeutics's Return On Capital Employed Insights
May 31, 2022
According to Benzinga Pro data, during Q1, Nektar Therapeutics (NASDAQ:NKTR) posted sales of $24.82 million. Earnings were up 37.94%, but Nektar Therapeutics still reported an overall loss of $90.39...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.